Ziprasidone (Geodon) For Schizophrenia
Ziprasidone (Geodon - Pfizer), a benzisothiazolyl piperazine, has been approved by the FDA for oral treatment of schizophrenia. An intramuscular formulation will probably be available in the near future....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Ziprasidone (Geodon) For Schizophrenia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1106
Article Code: 1106b
Date: June 11, 2001
Volume: 43
Pages: 51-52
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1106
Article Code: 1106b
Date: June 11, 2001
Volume: 43
Pages: 51-52
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)